doi: 10.1016/j.physbeh.2022.113967 Summary Keywords glucagon-like peptide-1 receptor agonists, psychiatric adverse events, disproportionality analyses, FAERS database, pharmacovigilance study Citation Chen W, Cai P, Zou W and Fu Z (2024) Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database
The paramagnetic probe, S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl methanesulfonothioate (MTSL), was used to label the cysteine residue 46 of p53 TAD 67 , where 300 M MTSL-labeled p53 TAD was added to 150 M 15 N-labeled FOXO4 FHD
Citation: Li AC-W, Lin Y-C, Huang J-Y, Chen L-C, Chua S-K (2025) Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study
This medication is gaining popularity for its ability to support significant weight loss by controlling appetite and blood sugar levels
It's a better predictor of cardiovascular events than LDL alone
Advice on correct posture along with the mechanics of the body is also provided as part of their services